FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385067488> ?p ?o ?g. }

• W4385067488 endingPage "536" @default.
• W4385067488 startingPage "518" @default.
• W4385067488 abstract "Cancerous tumor growth and inflammation stimulate the search for novel anticancer drugs. This pioneering study isolated Brevibacillus borstelensis NOB3 from a solar saltern and tested its bioactive substances for anticancer, antimicrobial, and anti-inflammatory activity. An in-silico test against HeLa cells was followed by an in-vitro MTT test. Agar well diffusion was used to examine the activity of the bioactive compounds of B. borstelensis NOB3 against spectrum human pathogenic bacteria and fungi. The highest clear zone was found with Bacillus subtilis (30 mm), followed by Escherichia coli and Candida albicans (28 mm); Pseudomonas aeruginosa and Staphylococcus aureus had a smaller zone of inhibition (25 mm). The minimum inhibitory concentration (MIC), was 31.25 g/ml against E. coli, followed by 62.5 g/ml against B. subtilis, P. aeruginosa, and C. albicans. Twenty-two bioactive substances were identified by (GC-MS). The binding energy of pyrazine, n-hexadecenoic acid, and oleic acid was measured for the cervical cancer target protein, and the findings were ‒5.1 kcal/mol, ‒4.6 kcal/mol, and ‒4.7 kcal/mol, respectively. In-vitro tests revealed potential action against the HeLa cell line with a half-maximal inhibitory concentration (IC50) of 68.46 g/ml. The novel halophilic B. borstelensis NOB3 has the potential to produce bioactive compounds for drug development." @default.
• W4385067488 created "2023-07-23" @default.
• W4385067488 creator A5003302584 @default.
• W4385067488 creator A5075029492 @default.
• W4385067488 creator A5077393808 @default.
• W4385067488 creator A5084586321 @default.
• W4385067488 date "2023-07-20" @default.
• W4385067488 modified "2023-09-27" @default.
• W4385067488 title "<i>In vitro</i> and molecular docking studies on a novel <i>Brevibacillus borstelensis</i> NOB3 bioactive compounds as anticancer, anti-inflammatory, and antimicrobial activity" @default.
• W4385067488 cites W1602814370 @default.
• W4385067488 cites W1631954758 @default.
• W4385067488 cites W1757407923 @default.
• W4385067488 cites W1900754193 @default.
• W4385067488 cites W1958319443 @default.
• W4385067488 cites W1967491708 @default.
• W4385067488 cites W1977741775 @default.
• W4385067488 cites W1985109786 @default.
• W4385067488 cites W1985629490 @default.
• W4385067488 cites W1995498845 @default.
• W4385067488 cites W1997476230 @default.
• W4385067488 cites W1997953796 @default.
• W4385067488 cites W2006651908 @default.
• W4385067488 cites W2007135866 @default.
• W4385067488 cites W2023614275 @default.
• W4385067488 cites W2049859532 @default.
• W4385067488 cites W2059795667 @default.
• W4385067488 cites W2069065723 @default.
• W4385067488 cites W2080669552 @default.
• W4385067488 cites W2097934563 @default.
• W4385067488 cites W2102468132 @default.
• W4385067488 cites W2116554142 @default.
• W4385067488 cites W2121253261 @default.
• W4385067488 cites W2125198887 @default.
• W4385067488 cites W2129706989 @default.
• W4385067488 cites W2132834292 @default.
• W4385067488 cites W2137631271 @default.
• W4385067488 cites W2150473133 @default.
• W4385067488 cites W2152207030 @default.
• W4385067488 cites W2204660769 @default.
• W4385067488 cites W2259649099 @default.
• W4385067488 cites W2322070537 @default.
• W4385067488 cites W2410250909 @default.
• W4385067488 cites W2415041632 @default.
• W4385067488 cites W2560254391 @default.
• W4385067488 cites W2621821410 @default.
• W4385067488 cites W2734825231 @default.
• W4385067488 cites W2739882170 @default.
• W4385067488 cites W2755444465 @default.
• W4385067488 cites W2779079094 @default.
• W4385067488 cites W2789271661 @default.
• W4385067488 cites W2799934885 @default.
• W4385067488 cites W2899736836 @default.
• W4385067488 cites W2944662322 @default.
• W4385067488 cites W2949715642 @default.
• W4385067488 cites W3003145860 @default.
• W4385067488 cites W3006682863 @default.
• W4385067488 cites W3015774864 @default.
• W4385067488 cites W3035552521 @default.
• W4385067488 cites W3120907531 @default.
• W4385067488 cites W3126997049 @default.
• W4385067488 cites W3131568246 @default.
• W4385067488 cites W3164038861 @default.
• W4385067488 cites W3164075292 @default.
• W4385067488 cites W3190738075 @default.
• W4385067488 cites W3193274740 @default.
• W4385067488 cites W4211223327 @default.
• W4385067488 cites W4289133993 @default.
• W4385067488 cites W4290829695 @default.
• W4385067488 cites W4292850925 @default.
• W4385067488 cites W4315754639 @default.
• W4385067488 cites W52392186 @default.
• W4385067488 cites W968562199 @default.
• W4385067488 doi "https://doi.org/10.1080/2314808x.2023.2236378" @default.
• W4385067488 hasPublicationYear "2023" @default.
• W4385067488 type Work @default.
• W4385067488 citedByCount "0" @default.
• W4385067488 crossrefType "journal-article" @default.
• W4385067488 hasAuthorship W4385067488A5003302584 @default.
• W4385067488 hasAuthorship W4385067488A5075029492 @default.
• W4385067488 hasAuthorship W4385067488A5077393808 @default.
• W4385067488 hasAuthorship W4385067488A5084586321 @default.
• W4385067488 hasBestOaLocation W43850674881 @default.
• W4385067488 hasConcept C104317684 @default.
• W4385067488 hasConcept C11636898 @default.
• W4385067488 hasConcept C145081991 @default.
• W4385067488 hasConcept C176947019 @default.
• W4385067488 hasConcept C185592680 @default.
• W4385067488 hasConcept C202751555 @default.
• W4385067488 hasConcept C2777272437 @default.
• W4385067488 hasConcept C2777366897 @default.
• W4385067488 hasConcept C2777752497 @default.
• W4385067488 hasConcept C2779489039 @default.
• W4385067488 hasConcept C2780104969 @default.
• W4385067488 hasConcept C2780917455 @default.
• W4385067488 hasConcept C4937899 @default.
• W4385067488 hasConcept C523546767 @default.
• W4385067488 hasConcept C54355233 @default.
• W4385067488 hasConcept C547475151 @default.

• next